Bank of Montreal
KLDO

Bank of Montreal’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Bank of Montreal’s Portfolio KLDO Stock Details KLDO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-468
Closed -$4K – 5387
2021
Q1 		$4K Sell
468
-1,363
-74% -$14.8K ﹤0.01% 4792
2020
Q4 		$22K Buy
1,831
+1,293
+240% +$10.6K ﹤0.01% 4387
2020
Q3 		$5K Sell
538
-229
-30% -$1.59K ﹤0.01% 4467
2020
Q2 		$5K Buy
+767
New +$5.14K ﹤0.01% 4436
2020
Q1 		– Sell
-1,434
Closed -$7K – 4953
2019
Q4 		$7K Buy
1,434
+883
+160% +$5.61K ﹤0.01% 4649
2019
Q3 		$4K Buy
551
+130
+31% +$1.13K ﹤0.01% 4593
2019
Q2 		$5K Buy
+421
New +$6.13K ﹤0.01% 4685

Other funds holding KLDO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of Montreal's KLDO Position: Q2 2021 in Review

Bank of Montreal sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2021, closing a stake of 468 shares — an estimated $4K sold.

Bank of Montreal first reported a position in KLDO in Q2 2019 and held it in 7 quarters. The position peaked at $22K in Q4 2020. 71 funds tracked by Wall St. Rank hold KLDO as of Q2 2021.

  • Bank of Montreal reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 468 Kaleido Biosciences, Inc. Common Stock shares in Q2 2021, an estimated $4K.
  • Bank of Montreal first reported a position in Kaleido Biosciences, Inc. Common Stock in Q2 2019 and held it in 7 quarters.
  • Bank of Montreal's Kaleido Biosciences, Inc. Common Stock position peaked at $22K in Q4 2020.
  • 71 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.